IL6 and COVID-19: A total of 64.3% of the patients had an acute COVID-19 condition of mild/moderate severity, and the remaining 35.7% suffered a severe condition requiring hospital admission, with expected alterations [31,32] in the admission analysis (elevated levels above AST, ALT, CRP, D-dimer, and IL-6 reference values).